Notice to Clarify Award Budget for RFA-NS-22-009 "Detecting Cognitive Impairment, Including Dementia, in Primary Care and Other Everyday Clinical Settings for the General Public and Health Equity, Pragmatic Clinical Trials (U01 Clinical Trial Required)"
Notice Number:
NOT-NS-22-038

Key Dates

Release Date:

October 26, 2021

Related Announcements

RFA-NS-22-009 - Detecting Cognitive Impairment, Including Dementia, in Primary Care and Other Everyday Clinical Settings for the General Public and Health Equity, Pragmatic Clinical Trials (U01 Clinical Trial Required)

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to clarify the Award Budget for Funding Opportunity Announcement (FOA) RFA-NS-22-009 "Detecting Cognitive Impairment, Including Dementia, in Primary Care and Other Everyday Clinical Settings for the General Public and Health Equity, Pragmatic Clinical Trials (U01 Clinical Trial Required)". Effective immediately, the Award Budget has been modified to show that application budgets are not limited, but need to reflect the actual needs of the proposed project. Language about limits to direct costs have been removed. Changes to the FOA are shown below.

Currently Reads:

Section II. Award Information

Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project. Up to $1,000,000 direct costs (DC) per year may be budgeted.

Modified to Read:

Section II. Award Information

Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project.


All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Roderick A. Corriveau, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-5680
Email: roderick.corriveau@nih.gov

Rebecca Hommer, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-9135
Email: rebecca.hommer@nih.gov